Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.113800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Rui Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Department of Medicine, McGill U…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Cytomegalovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genome Canada, CIHR, NSERC.
Abstract (Originalsprache)
Infection of mice by mouse cytomegalovirus (MCMV) triggers activation and expansion of Ly49H+ natural killer (NK) cells, which are virus specific and considered to be "adaptive" or "memory" NK cells. Here, we find that signaling lymphocytic activation molecule family receptors (SFRs), a group of hematopoietic cell-restricted receptors, are essential for the expansion of Ly49H+ NK cells after MCMV infection. This activity is largely mediated by CD48, an SFR broadly expressed on NK cells and displaying augmented expression after MCMV infection. It is also dependent on the CD48 counter-receptor, 2B4, expressed on host macrophages. The 2B4-CD48 axis promotes expansion of Ly49H+ NK cells by repressing their phagocytosis by virus-activated macrophages through inhibition of the pro-phagocytic integrin lymphocyte function-associated antigen-1 (LFA-1) on macrophages. These data identify key roles of macrophages and the 2B4-CD48 pathway in controlling the expansion of adaptive NK cells following MCMV infection. Stimulation of the 2B4-CD48 axis may be helpful in enhancing adaptive NK cell responses for therapeutic purposes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Oncology, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Department of Medicine, McGill University, Montréal, QC H3G 1Y6, Canada.
- Laboratory of Molecular Oncology, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada.
- Laboratory of Molecular Oncology, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, QC H2W 1R7, Canada; Molecular Biology Program, University of Montréal, Montréal, QC H3T 1J4, Canada.
- Institute of Virology, University Medical Center, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
- Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.
- Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Förderung
- Genome Canada
- CIHR
- NSERC
- IDRC
Zitieren
APA
Li, R., Galindo, C. C., Davidson, D., Guo, H., Zhong, M. C., Qian, J., Li, B., Ruzsics, Z., Lau, C. M., O'Sullivan, T. E., Vidal, S. M., Sun, J. C., & Veillette, A. (2024). Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48. Cell Reports. https://doi.org/10.1016/j.celrep.2024.113800
Vancouver
Li R, Galindo CC, Davidson D, Guo H, Zhong MC, Qian J, et al. Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48. Cell Reports. 2024. doi:10.1016/j.celrep.2024.113800
BibTeX
@article{Li2024,
author = {Li, Rui and Galindo, Cristian Camilo and Davidson, Dominique and Guo, Huaijian and Zhong, Ming-Chao and Qian, Jin and Li, Bin and Ruzsics, Zsolt and Lau, Colleen M and O'Sullivan, Timothy E and Vidal, Silvia M and Sun, Joseph C and Veillette, André},
title = {Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.113800}
}
EUVIMED